retatrutide weight loss clinical trials retatrutide New Phase 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide, Eli Lilly's next generation

Novo Nordisk acquired the Catalant facility in late 2024

Accessed October 2025

People with active inflammatory bowel disease: While probiotics can sometimes help IBD, introducing new strains during an active flare requires medical supervision

Food moves through your stomach at normal speed when only GIP receptors are activated

(2019) reported that urinary NGAL accurately predicted AKI development in 27 subjects, identifying NGAL as a strong early marker of AKI. Despite this, managing CKD in liver transplant recipients remains challenging, with limited options to prevent or mitigate the progression of kidney damage

GLP-1 Patches from Kind Patches The folks over at Kind Patches are certainly keeping things interesting